echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > The new coronavirus mRNA vaccine independently developed by RiboBio and Agna Biopharmaceuticals has started clinical trials

    The new coronavirus mRNA vaccine independently developed by RiboBio and Agna Biopharmaceuticals has started clinical trials

    • Last Update: 2022-02-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On January 10, 2022, the Phase I clinical trial of mRNA vaccine for the prevention of novel coronavirus pneumonia was officially launched in Chengdu


    Vaccination is one of the most effective public health interventions to prevent and control infectious diseases


    With the support of the government's new crown emergency research project, Ribo Bio, Agna Biopharmaceutical, the Guangzhou Institute of Biomedicine and Health of the Chinese Academy of Sciences and the Guangzhou National Laboratory carried out scientific research cooperation, and jointly carried out the mRNA of the original strain and variant strain of the new coronavirus Vaccine development and production


    RiboBio is China's leading nucleic acid technology benchmarking enterprise and a key high-tech enterprise of the National Torch Program.


    Agna Biopharmaceuticals is a biopharmaceutical company founded by the world's top scientists.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.